These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30820213)

  • 1. Comparison of Two Statistical Methods to Determine Normal Range of Androgen Hormones: K-Means Cluster Analysis and Receiver Operating Characteristic Curve.
    Ramezani-Tehrani F; Rahmani K; Moradi A; Montazeri SA; Bidhendi-Yarandi R; Darabi F
    J Family Reprod Health; 2018 Jun; 12(2):96-102. PubMed ID: 30820213
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age.
    Hashemi S; Ramezani Tehrani F; Noroozzadeh M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():51-5. PubMed ID: 24220143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age.
    Zhao X; He Z; Mo Y; Chen X; Chen Y; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):187-91. PubMed ID: 21111526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference range of testosterone and dehydroepiandrosterone sulfate levels in women during reproductive age in the Iranian population.
    Meamar R; Feizi A; Aminorroaya A; Amini M; Iraj B; Heidarpour M
    J Res Med Sci; 2023; 28():69. PubMed ID: 38116488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variations of androstenedione, dehydroepiandrosterone sulfate and free testosterone in obese women with menstrual disturbances.
    Ostrowska Z; Zwirska-Korczala K; Pardela M; Drozdz M; Kos-Kudla B; Buntner B
    Endocr Regul; 1998 Dec; 32(4):169-176. PubMed ID: 10200588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
    Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
    Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
    Keane KN; Hinchliffe PM; Namdar N; Conceicao JL; Newsholme P; Yovich JL
    Drug Des Devel Ther; 2015; 9():5569-78. PubMed ID: 26487801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
    Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D; Kristesashvili J
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.